Placental Transfer of Drugs Administered to the Mother

Clinical Pharmacokinetics

Volumn 28, Issue 3, 1995, Pages 235-269

  Pacifici, Gian Maria ^a   Nottoli, Rita ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ADRENERGIC RECEPTOR STIMULATING AGENT; AMIODARONE; AMOXICILLIN; AMPICILLIN; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIULCER AGENT; ANTIVIRUS AGENT; ATROPINE; BENZODIAZEPINE; BETAMETHASONE; CANNABINOID; CARDIAC GLYCOSIDE; CEFTAZIDIME; DICOUMAROL; DIURETIC AGENT; FOLIC ACID; INDOMETACIN; LIOTHYRONINE; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; NORADRENALIN; THYROXINE; UNINDEXED DRUG; XANTHINE;

DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TRANSPORT; FEMALE; FETUS; FETUS BLOOD; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MATERNAL PLASMA; MOLECULAR WEIGHT; ORAL DRUG ADMINISTRATION; PLACENTA; PLACENTA CIRCULATION; PLACENTAL TRANSFER; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW;

ANESTHETICS; ANTIBIOTICS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTINEOPLASTIC AGENTS; CARDIOVASCULAR AGENTS; FEMALE; FETUS; HUMAN; MATERNAL-FETAL EXCHANGE; PHARMACOKINETICS; PLACENTA; PREGNANCY;

EID: 0028945203     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/00003088-199528030-00005     Document Type: Review

References (291)

1. Placental transfer of ampicillin
2. Placental transfer of methicillin
3. Transfer of drugs across the placenta
4. Transmission of drugs across the placenta
5. Transport functions of the placenta
6. Passage of drugs across the placenta
7. Placental transfer of drugs
8. Drugs in the first trimester of pregnancy and the foetal life of homosapiens
9. Drugs as teratogens in animals and man
10. Perinatal pharmacology
11. Placental drug transfer
12. Placental transfer of drugs and their distribution in foetal tissues
13. Drug disposition and pharmacokinetics in the maternal-placental-foetal unit
14. Perinatal pharmacology placental transfer, foetal localization and neonatal disposition of drugs
15. Placental transfer of pharmacologically active molecules
16. Transmission of the anesthetic agents through the placenta in painless delivery and their effects on newborn infants
17. Obstetric anesthesia and concepts of placental transport a historical review of the nineteenth century
18. Placental passage of anesthetics
19. Placental transfer and drugs used in anesthesia
20. Uptake, distribution and placental transport of drugs and anesthetics
21. The effects of drugs used in labor on the foetus and newborn
22. Clinical pharmacokinetics in pregnancy and perinatology I: placental transfer and foetal side effects of local anaesthetic agents
23. Passaggio transplacentare dei farmaci anestetici
24. Placental transfer of local anesthetics
25. Anticonvulsants during pregnancy and lactation
26. Placental transmission of antibiotics
27. Clinical pharmacokinetics in the treatment of rheumatoid arthritis in pregnancy
28. The effects of pharmacological agents upon the foetus and newborn
29. Drugs in pregnancy: effects on the foetus and newborn
30. Effects of drugs on the foetus and neonate
31. Maternal medication and its effect on the foetus
32. Drug use in pregnancy: how to avoid problems
33. Fetal and neonatal effects of drugs in obstetrics
34. The epidemiology of alcohol, marijuana, and cocaine use among women of childbearing age and pregnant women
35. Kinetics of drug transfer to the foetus
36. Cocaine, heroin, phencyclidine: obstetric perspectives
37. The impact of prenatal marijuana and cocaine use on the infant and child
38. Morphometry of the human placenta
39. Quantitative aspects of placental structure
40. New studies on placental transfer of fosfomycin
41. Nitrous oxide transfer across the placenta and condition of the newborn at delivery
42. The significance of placental/fetal weight ratios
43. Measurement of uterine blood flow and uterine metabolism: IV. Results in normal pregnancy
44. Estimation of uterine blood flow in normal pregnancy at term
45. A theoretical analysis of fetal drug equilibration
46. In vitro permeability of different layers of human placenta to carbohydrates and urea
47. Transfer of charged and uncharged particles in the placenta of the rabbit
48. Methods of determining plasma and tissue binding of drugs
49. Placental gas transfer
50. Gas exchange across the placenta
51. Transfer of carbohydrates across guinea pig placenta
52. Placental transfer
53. Transfer of D-and L-histidine across the human placenta
54. Pancuronium in caesarean section and its placental transfer
55. Thiamphenicol during the first trimester of human pregnancy placental transfer in vivo, placental uptake in vitro and inhibition of mitochondrial function
56. The ingestion of proteins and colloid materials by columnar absorptive cells of the small intestine in suckling rats and mice
57. On the phagocytosis of iron-dextran by the human plasmoditrophoblast
58. Regional specializations in the syncytial trophoblast of early human placenta
59. The functional role of the placenta
60. The functional role of the placenta
61. Transport mechanism in the fetus
62. Placental transfer of cefazolin and piperacillin in pregnancies remote from term complicated by Rh-isoimmunization
63. Placental transfer of indomethacin in the human pregnancy
64. Placental passage of azathiothymidine (AZT) during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound
65. Maternal and foetal blood levels after administration of oxytetracycline
66. Transplacental passage of primidone
67. Fetoplacental passage of zidovudine
68. Placental transfer of alfentanil at caesarean section
69. Transmission of lidocaine hydrochloride across the placenta during caesarian section
70. Placental transfer of phenobarbitone in epileptic women, and elimination in newborns
71. Levels of ritodrine hydrochloride in fetal blood and amniotic fluid following long term continuous administration in late pregnancy
72. A transfer of a new cephalosporin antibiotic to the foetus and the amniotic fluid during a continuous infusion (steady state) and a single repeated intravenous injections to the mother
73. Comparison of the placental transfer of thiopental and diazepam in cesarean section
74. The influence of dose-delivery time interval on neonatal plasma pethidine levels
75. Etude du passage transplacentaire des beta-lactamines
76. Transplacental ampicillin inhibitory concentrations in neonatal serum
77. Transplacental passage of ampicillin
78. Distribution of parenteral ampicillin and cephalosporins in late pregnancy
79. Study of ampicillin levels in maternal serum, umbilical cord serum and amniotic fluid following administration of pivampicillin
80. The passage of ampicillin into the liquor amnii and the foetal circulation
81. The prophylactic use of ampicillin and its trans-placental passage after amniotomy
82. Materno-foetal transfer of azlocillin
83. Placental transfer of dicloxacillin at term
84. Transplacental passage of methicillin and dicloxacillin into the foetus and amniotic fluid
85. Placental transfer of disodium sulbenicillin
86. Placental transfer of cefmenoxime in late pregnancy
87. Etude du passage transplacentaire du cefotaxime
88. A study of the transplacental transfer and the mammary excretion of cefoxitin in humans
89. Placental transfer of cefuroxime
90. Cefuroxim passaggio transplacentare e concentrazioni nell’utero e annessi
91. Achievement of therapeutic concentrations of cefuroxime in early preterm gestation with premature rupture of the membranes
92. Transplacental transfer of cefuroxime in uncomplicated pregnancies and those complicated by hydrops or changes in amniotic fluid volume
93. Placental transmission of cephaloridine
94. Transfer of cephaloridine from mother to foetus
95. Transfer of limecycline and cephaloridine from mother to foetus: a comparative study
96. Serum concentrations of cephalothin in infants and children and placental transmission of the antibiotic
97. The behavior of cephalothin in amniotic fluid
98. Transfer of cephalothin sodium to the foetus
99. Maternal-foetal pharmacological activity of amikacin
100. Studio del passaggio transplacentare di amminosidina
101. Placental transfer of gentamicin
102. Placental transfer and foetal urinary excretion of gentamicin during constant rate maternal infusion
103. The placental transfer of kanamycin during late pregnancy
104. Transmission of streptomycin from maternal blood to the foetal circulation and the amniotic fluid
105. The transfer of clomocycline (Megaclor) across the human placenta
106. Transfer of tetracycline across the human placenta
107. Sul passaggio transplacentare del cloroamfenicolo somministrato alla madre per via orale
108. Placental transmission of colistimethate
109. Placental transfer of griseofulvin
110. Osservazioni sul passaggio transplacentare delle rifamicine
111. Placental and mammary transfer of sulphasalazine
112. Transplacental passage of vancomycin during the second trimester of pregnancy
113. Pharmacokinetics of acyclovir in the term human pregnancy and neonate
114. Perinatal pharmacokinetics of zidovudine
115. Zidovudine concentrations in human fetal tissues implications for perinatal AIDS
116. Pharmacokinetics of zidovudine (Azidothymidine): I transplacental transfer
117. Does doxorubicin cross the placenta?
118. Doxorubicin in pregnancy: possible transplacental passage
119. Transplacental passage of doxorubicin
120. Transplacental passage of cyclophosphamide
121. Placental transfer of methoxyflurane
122. Pharmacokinetics and placental transfer of alfentanil in parturient women
123. Study of ketamine as an obstetric anesthetic agent
124. Transplacental passage of ketamine after intravenous administration
125. Placental transmission of pentobarbital sodium
126. Intravenous propofol during cesarean section placental transfer, concentrations in breast milk, and neonatology effect: a preliminary study
127. Disposition of propofol infusions for caesarean section
128. Blood secobarbital levels and their clinical correlation in mothers and newborn infants
129. Intravenous thiobarbiturate anesthesia for cesarean section
130. Some aspects of obstetric anaesthesia
131. Placental transmission of thiopental
132. Tissue thiopental concentrations in the fetus and newborn
133. Epidural anesthesia with bupivacaine for cesarean section: neonatal blood levels and neurobehavioral responses
134. The maternal plasma levels and placental transfer of bupivacaine following epidural analgesia
135. Placental transfer of bupivacaine after paracervical block
136. Maternal and neonatal blood concentrations of bupivacaine associated with obstetrical conduction anesthesia
137. Plasma protein binding and placental transfer of bupivacaine
138. Disposition and placental transfer of etidocaine in pregnancy
139. Plasma levels of lidocaine (xylocaine) in mother and newborn following obstetrical conduction
140. Passage of lidocaine and prilocaine across the placenta
141. The kinetics of transfer of lidocaine (xylocaine) across the human placenta
142. Newborn blood levels of lidocaine and mepivacaine in the first postnatal day following maternal epidural anesthesia
143. Placental transfer of lidocaine and its uptake by the fetal tissues
144. Transmission of carbonated lidocaine across the placenta during caesarean section
145. Placental transfer of lidocaine following paracervical block
146. The influence of adrenaline on the maternal plasma levels and placental transfer of lignocaine following lumbar epidural administration
147. Blood concentration of mepivacaine and lidocaine in mother and baby after epidural anesthesia
148. Transmission of mepivacaine hydrochloride (carbocaine) across the human placenta
149. Paracervical block anesthesia in obstetrics
150. Foetal bradycardia after paracervical block
151. Foetal and maternal plasma levels of mepivacaine and foetal acid-base balance and heart rate after paracervical block during labour
152. Transplacental transfer of morphine in man
153. Comparison of pentazocine and pethidine in normal labor
154. Placental transfer of paracetamol
155. Meperidine and normeperidine levels following meperidine administration during labor
156. The placental transmission of pethidine
157. Placental transfer of pethidine and norpethidine and their pharmacokinetics in the newborn
158. The placental transfer of pentazocine and pethidine
159. The use of prilocaine hydrochloride (citanest) for epidural analgesia in obstetrics
160. Passage of procaine hydrochloride and para-aminobenzoic acid across the human placenta
161. Foetal effects of regular salicylate ingestion in pregnancy
162. The distribution of sodium salicylate in the human foetus
163. Foetal acquisition and neonatal elimination of a large amount of salicylate
164. Kinetics of salicylate elimination by newborn infants of mothers who ingested aspirin before delivery
165. Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk
166. Disposition of placentally transferred carbamazepine (tegretol) in the newborn
167. Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA, hydroxyphenobarbital in neonates and infants of epileptic mothers
168. Placental transfer of anticonvulsants (phenobarbital, phenytoin and valproic acid) and the elimination from neonates
169. Placental transfer and neonatal elimination of diphenylhydantoin
170. Diphenylhydantoin placental transport, foetal localization and neonatal metabolism: possible teratogenic effects
171. Transmission of valproic acid (depakene) across the placenta: half-life of the drug in mother and baby
172. Valproic acid and its metabolites placental transfer, neonatal pharmacokinetics and transfer via mother’s milk: clinical status in neonates of epileptic mothers
173. Transplacental passage, half-life of sodium valproate in infants born to epileptic mothers
174. The determination of blood levels and the placental transfer of diazepam in humans
175. Diazepam: a pilot study of drug concentrations in maternal blood, amniotic fluid and cord blood
176. Diazepam in labour: its metabolism, effect on clinical condition and thermogenesis of newborn
177. A study of plasma diazepam levels in mother and infant
178. Accumulation of diazepam, N-demethyldiazepam in the foetal blood during the labour
179. Placental transfer of diazepam: its disposition in the newborn
180. The effects of diazepam on the foetus
181. Diazepam in pre-eclamptic toxaemia with special reference to its effect on the newborn infant
182. Transplacental passage of diazepam following intravenous injection immediately prior to operative vaginal delivery
183. Transplacental passage of diazepam during labor: influence of uterine contractions
184. Foetal drug exposure following intravenous injection of diazepam immediately before breech delivery
185. Time-course of transplacental passage of diazepam influence of injection-delivery interval on neonatal drug concentrations
186. Diazepam as an induction agent for cesarean section: a clinical, pharmacokinetic study of foetal drug exposure
187. Placental transfer and foetal metabolism of diazepam in early human pregnancy
188. Diazepam in early human pregnancy
189. The use of chlordiazepoxide in patients with severe pregnancy toxaemia
190. Transfer of nitrazepam across the human placenta
191. A study of the plasma concentrations of lorazepam in mother and neonate
192. Transfer of free, conjugated oxazepam across the human placenta
193. Placental passage of oxazepam: its metabolism in mother and newborns
194. Placental transfer and maternal midazolam kinetics
195. Pharmacokinetics of the placental transfer and distribution of clorazepate and its metabolite nordiazepam in the feto-placental unit and neonate
196. Placental transfer of pinazepam and its metabolite N-desmethyldiazepam in women at term
197. Plasma disappearance of nortriptyline in a newborn infant following placental transfer from an intoxicated mother: evidence for drug metabolism
198. The mode of administration of promazine as a factor in determining the extent of placental transmission
199. Placental transfer and pharmacokinetics of acebutolol and N-acetyl acebutolol in the newborn
200. Transplacental passage of atenolol in man
201. Placental transfer and perinatal pharmacokinetics of betaxolol
202. Betaxolol a pilot study of its pharmacological and therapeutic properties in pregnancy
203. Studies on placental transfer of celiprolol
204. Clonidine placental transfer and neonatal adaption
205. Transplacental passage of isradipine in the treatment of pregnancy-induced hypertension
206. A study of the transfer of alpha-methyldopa to the human foetus and newborn infant
207. Study of the disposition of alpha-methyldopa in newborn infants following its administration to the mother for the treatment of hypertension during pregnancy
208. Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in the human fetus
209. Weak transplacental passage of prazosin (Alpress) during the third trimester of pregnancy
210. Transfer of propranolol and sotalol across the human placenta
211. Metabolism of propranolol in the human maternal-placental-foetal unit
212. Placental transfer of chlorthalidone and its elimination in maternal milk
213. Placental transfer of etozolin and ozolinone during the first half of gestation in man
214. Placental transfer of furosemide
215. Placental transfer of hydrochlorothiazide
216. The placental transfer of alcuronium
217. Use of atracurium in caesarean section
218. Placental transfer of dantrolene
219. 14C-dimethyltubocurarine during cesarean section
220. 14C-dimethyltubocurarine
221. Quantitative assessment of placental transfer of fazadinium in obstetric anaesthesia
222. Pharmacokinetics, placental transmission of fazadinium in elective cesarean sections
223. The placental transfer of pancuronium and its pharmacokinetics during cesarian section
224. Pharmacokinetics, placental transfer and neonatal effects of vecuronium and pancuronium administered during caesarean section
225. The placental transmission of succinylcholine
226. l4C-labelled succinylcholine in near-term Macaca mulatta Monkeys
227. Placental transfer of succinylcholine causing transient respiratory depression in the newborn
228. Placental transfer of tubocurarine
229. Placental transfer of ORG NC45 in women undergoing caesarean section
230. Transfer of digoxin across the placenta and into breast milk
231. Placental transfer of digoxin (beta-methyl-digoxin) in man
232. Insufficient transplacental digoxin transfer in severe hydrops foetalis
233. 3H-digoxin in humans
234. The foeto-maternal distribution of digoxin in early human pregnancy
235. Placental transfer of radioactive digitoxin in pregnant women and its foetal distribution
236. The placental transfer of cimetidine
237. Cimetidine as pre-anesthetic agent for cesarean section: perinatal effects on the infant and the placental transfer of cimetidine and its elimination in the infants
238. Placental transport of metoclopramide assessment of maternal effects
239. Pharmacokinetics and maternal-fetal influence of ritodrine hydrochloride during the continuous treatment of threatened premature labor
240. Ritodrine concentrations in maternal and foetal serum and amniotic fluid
241. Transfer of ritodrine and norepinephrine in human placenta: in vivo study
242. Transfer of terbutaline across the human placenta in late pregnancy
243. Single injection of terbutaline in term labor: placental transfer and effects on maternal and foetal carbohydrate metabolism
244. Maternal-foetal transfer of aminophylline
245. Placental transfer of theophylline: two case reports
246. Use of amiodarone during pregnancy
247. Placental transfer of atropine at the end of pregnancy
248. Placental transfer and pharmacokinetics of atropine after a single maternal intravenous and intramuscular administration
249. Quantitative measurements of placental transfer and distribution of radioactive atropine in human fetus
250. The placental transfer of betamethasone
251. Human placental transfer of cannabinoids
252. Transplacental transfer of bishydroxycoumarin in the human
253. Transfer of folate to the foetus
254. Transition of noradrenaline across the human placenta
255. Passage of thyroxine, tri-iodo-thyronine from mother to foetus in pregnant women
256. Infectious disorders
257. Exogenous hormones, other drug exposures of children with congenital heart failure
258. Intrauterine ototoxicity: a case report and review of the literature
259. Clinical aspects of the teratogenicity of drugs
260. Vecuronium-thiopentone induction for emergency caesarean section under general anaesthesia
261. Diagnosis, treatment and follow-up of neonatal mepivacaine intoxication secondary to paracervical and pudendal blocks during labor
262. The fetal and neonatal effects of regional anesthesia in obstetrics
263. Lidocaine and its metabolism in the newborn
264. Metabolism of local anaesthetics in the fetus, newborn and adult
265. Antiepileptic drug therapy in pregnancy
266. The teratogenic risk of antiepileptic drugs
267. Antiepileptic drugs and pregnancy: altered utilization pattern and teratogenicity
268. Drugs in special patient groups: pregnancy and nursing
269. Fetal outcome in trial of antihypertensive treatment in pregnancy
270. Treatment of hypertension in pregnancy with methyldopa blood pressure control: side effects
271. Beta-blockers in pregnancy
272. Atenolol in essential hypertension during pregnancy
273. Atenolol in the treatment of essential hypertension during pregnancy